192 related articles for article (PubMed ID: 35421352)
1. A unique mode of nucleic acid immunity performed by a multifunctional bacterial enzyme.
Bari SMN; Chou-Zheng L; Howell O; Hossain M; Hill CM; Boyle TA; Cater K; Dandu VS; Thomas A; Aslan B; Hatoum-Aslan A
Cell Host Microbe; 2022 Apr; 30(4):570-582.e7. PubMed ID: 35421352
[TBL] [Abstract][Full Text] [Related]
2. Landscape of New Nuclease-Containing Antiphage Systems in Escherichia coli and the Counterdefense Roles of Bacteriophage T4 Genome Modifications.
Wang S; Sun E; Liu Y; Yin B; Zhang X; Li M; Huang Q; Tan C; Qian P; Rao VB; Tao P
J Virol; 2023 Jun; 97(6):e0059923. PubMed ID: 37306585
[TBL] [Abstract][Full Text] [Related]
3. A single bacterial enzyme i(NHI)bits phage DNA replication.
Huiting E; Bondy-Denomy J
Cell Host Microbe; 2022 Apr; 30(4):417-419. PubMed ID: 35421333
[TBL] [Abstract][Full Text] [Related]
4. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
[TBL] [Abstract][Full Text] [Related]
5. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
[TBL] [Abstract][Full Text] [Related]
6. A DNA phosphorothioation-based Dnd defense system provides resistance against various phages and is compatible with the Ssp defense system.
Jiang S; Chen K; Wang Y; Zhang Y; Tang Y; Huang W; Xiong X; Chen S; Chen C; Wang L
mBio; 2023 Aug; 14(4):e0093323. PubMed ID: 37260233
[TBL] [Abstract][Full Text] [Related]
7. Strategies for Editing Virulent Staphylococcal Phages Using CRISPR-Cas10.
Bari SMN; Walker FC; Cater K; Aslan B; Hatoum-Aslan A
ACS Synth Biol; 2017 Dec; 6(12):2316-2325. PubMed ID: 28885820
[TBL] [Abstract][Full Text] [Related]
8. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
Maniv I; Jiang W; Bikard D; Marraffini LA
J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
[TBL] [Abstract][Full Text] [Related]
9. Phage-Encoded Anti-CRISPR Defenses.
Stanley SY; Maxwell KL
Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
[TBL] [Abstract][Full Text] [Related]
10. Why put up with immunity when there is resistance: an excursion into the population and evolutionary dynamics of restriction-modification and CRISPR-Cas.
Gurney J; Pleška M; Levin BR
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180096. PubMed ID: 30905282
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas10 assisted editing of virulent staphylococcal phages.
Nayeemul Bari SM; Hatoum-Aslan A
Methods Enzymol; 2019; 616():385-409. PubMed ID: 30691652
[TBL] [Abstract][Full Text] [Related]
12. Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection.
Mayo-Muñoz D; Smith LM; Garcia-Doval C; Malone LM; Harding KR; Jackson SA; Hampton HG; Fagerlund RD; Gumy LF; Fineran PC
Mol Cell; 2022 Dec; 82(23):4471-4486.e9. PubMed ID: 36395770
[TBL] [Abstract][Full Text] [Related]
13. How bacteria control the CRISPR-Cas arsenal.
Leon LM; Mendoza SD; Bondy-Denomy J
Curr Opin Microbiol; 2018 Apr; 42():87-95. PubMed ID: 29169146
[TBL] [Abstract][Full Text] [Related]
14. Unveil the Secret of the Bacteria and Phage Arms Race.
Wang Y; Fan H; Tong Y
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901793
[TBL] [Abstract][Full Text] [Related]
15. Cleavage of viral DNA by restriction endonucleases stimulates the type II CRISPR-Cas immune response.
Maguin P; Varble A; Modell JW; Marraffini LA
Mol Cell; 2022 Mar; 82(5):907-919.e7. PubMed ID: 35134339
[TBL] [Abstract][Full Text] [Related]
16. Antiphage small molecules produced by bacteria - beyond protein-mediated defenses.
Hardy A; Kever L; Frunzke J
Trends Microbiol; 2023 Jan; 31(1):92-106. PubMed ID: 36038409
[TBL] [Abstract][Full Text] [Related]
17. Nucleic Acid Immunity.
Hartmann G
Adv Immunol; 2017; 133():121-169. PubMed ID: 28215278
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional evidence of bacterial antiphage protection by Thoeris defense system via NAD
Ka D; Oh H; Park E; Kim JH; Bae E
Nat Commun; 2020 Jun; 11(1):2816. PubMed ID: 32499527
[TBL] [Abstract][Full Text] [Related]
19. Bacterial alginate regulators and phage homologs repress CRISPR-Cas immunity.
Borges AL; Castro B; Govindarajan S; Solvik T; Escalante V; Bondy-Denomy J
Nat Microbiol; 2020 May; 5(5):679-687. PubMed ID: 32203410
[TBL] [Abstract][Full Text] [Related]
20. Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage.
Meeske AJ; Nakandakari-Higa S; Marraffini LA
Nature; 2019 Jun; 570(7760):241-245. PubMed ID: 31142834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
